A new human liver organoid platform could help predict which drugs trigger dangerous immune reactions in susceptible patients ...

MoldCo is here to change that with clinical rigor based on 30+ years of research, affordability, and accessibility—redefining a space long characterized by confusion, cost, and neglect.

In the histology-centric world of cancer medicine, further work is needed to increase genomic testing rates and educate ...

A secondary analysis of TRAILBLAZER-ALZ 2 strengthens the case that reducing amyloid plaques underlies the clinical benefits ...

South Florida oncologists are seeing an alarming rise in a hard-to-detect breast cancer that is increasing at more than ...

Patients in Wales could be some of the first to benefit new research looking at how Artificial Intelligence combined with ...

The market for biomarker discovery outsourcing is expanding rapidly, driven by precision medicine, AI analytics, and growing pharma–CRO collaborations. LONDON, UNITED KINGDOM, October 16, 2025 ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

In short, this research could lead to life-saving changes in how ILD is diagnosed and treated. By catching the disease early ...

LONDON, GREATER LONDON, UNITED KINGDOM, October 15, 2025 / EINPresswire.com / -- "Get 20% Off All Global Market Reports With Code ONLINE20 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And ...

The FDA has cleared Roche's Elecsys pTau181 test, a blood-based biomarker test for Alzheimer's disease, allowing for earlier ...